| 1 |
Safety and effectiveness of lanthanum carbonate for hyperphosphatemia in chronic kidney disease (CKD) patients: a meta-analysis |
|
| | Lijuan Zhao, An Liu, Guoshuang Xu | | | Renal Failure. 2021; 43(1): 1378 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD) |
|
| | Marinella Ruospo, Suetonia C Palmer, Patrizia Natale, Jonathan C Craig, Mariacristina Vecchio, Grahame J Elder, Giovanni FM Strippoli | | | Cochrane Database of Systematic Reviews. 2018; 2018(8) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Efficacy and safety of lanthanum carbonate versus calcium-based phosphate binders in patients with chronic kidney disease: a systematic review and meta-analysis |
|
| | Chun-Juan Zhai,Xiao-Wei Yang,Jing Sun,Rong Wang | | | International Urology and Nephrology. 2014; | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Cost-Effectiveness of Lanthanum Carbonate in the Treatment of Hyperphosphatemia in Chronic Kidney Disease Before and During Dialysis |
|
| | Stefan Vegter, Keith Tolley, Michael S. Keith, Maarten J. Postma | | | Value in Health. 2011; | | | [HTML Full text] [Google Scholar] [DOI] | |
|
